| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |